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ABSTRACT  
Several forms of monogenic heritable autism spectrum disorders are associated to mutations 
in the Neuroligin genes. The autism-linked substitution arginine 451 to cysteine (R451C) in 
Neuroligin3 induces local misfolding of its extracellular domain, causing partial retention in the 
endoplasmic reticulum. Endoplasmic reticulum stress due to the accumulation of misfolded 
proteins can eventually result in the unfolded protein response (UPR). We have generated a 
PC12 Tet-On cell system with inducible expression of Neuroligin3 that enabled us to study 
whether the expression of either wild type or R451C proteins leads to the activation of the 
UPR. As a control mutation, we have used the G221R substitution in Neuroligin3, which is 
known to cause complete retention of the protein in the endoplasmic reticulum. Our data 
show that over-expression of either R451C or G221R mutant proteins leads to the activation 
of all three signaling branches of the UPR downstream of the stress sensors ATF6, IRE1, and 
PERK. Each branch displays its own time-dependent activation and reflects the severity of the 
impact caused by the mutations on Neuroligin3 folding. We show here that up-regulation of 
BiP and CHOP, is induced by both mutants but not by the wildtype protein. This effect is 
retained by PC12 following in vitro neuronal differentiation. Our data show for the first time 
that misfolding mutations such as Neuroligin3 R451C activates the UPR in a heterologous cell 
system, and suggest that these cellular responses may have a role in increasing the risk of 
autism . 
Summary statement 
Expression of Neuroligin3, carrying the autism related R451C mutation in neuronal-like PC12 
cells induces endoplasmic reticulum stress, leading to the activation of signaling finalized to 
the upregulation of downstream target genes that restore ER homeostasis. 
Short title:  Neurolign 3 misfolding mutations and activation of the unfolded protein response 
Keywords: neuroligin, ER stress, unfolded protein response, autism, protein misfolding, 
molecular chaperones.  
List of abbreviations: NLGN3: Neuroligin3; ER: endoplasmic reticulum; UPR: unfolded 
protein response; HRP: horseradish peroxidase; SDS: sodium dodecyl sulfate, PAGE: 
polyacrylamide gel electrophoresis.  
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INTRODUCTION 
Genetic studies of monogenic forms of autism spectrum disorders (ASDs) have identified in 
the synaptic function one of the molecular pathways underlying neurodevelopmental 
disorders {Pinto, 2014 #493}. Among the most studied susceptibility genes are the 
Neuroligins (NLGNs), postsynaptic cell adhesion proteins involved in the maturation, 
specification and plasticity of neuronal networks through the interaction with presynaptic 
Neurexins {Sudhof, 2008 #483}. Rare human autism-linked mutations in the NLGNs genes 
have been shown to affect protein folding and their trafficking to the cell surface. 
The R451C single point mutation in NLGN3, an X-linked gene, was found in association with 
highly penetrant autism in a Swedish family {Jamain, 2003 #60}. The R451C NLGN3 protein 
has been extensively characterized in over-expression studies in several systems {Comoletti, 
2004 #125;Chih, 2004 #286;Chubykin, 2005 #482;De Jaco, 2006 #75} where partial retention 
in the endoplasmic reticulum (ER) results from local misfolding of the extracellular domain of 
NLGN3 caused by the R451C mutation (Fig. 1A). It was shown that ER retention of R451C 
NLGN3 results from the selective association with molecular chaperones, such as BiP. 
Whereas most of the mutant protein is degraded, residual protein is correctly trafficked to the 
cell surface {De Jaco, 2010 #69}. Consistent with the in vitro studies, in vivo work using 
knockin (KI) R451C NLGN3 mice, shows that this mutation causes a 90% reduction of 
NLGN3 protein. This reduction is likely due to degradation {Tabuchi, 2007 #143}. 
A group of diseases called endoplasmic reticulum storage diseases (ERSD), includes 
disorders characterized by protein misfolding and recognition by the endoplasmic reticulum 
(ER) quality control system {Rutishauser, 2002 #484}. These disorders may be triggered by 
ER retention of excess misfolded protein and/or by the lack of the functional protein in the 
correct subcellular location. ERSDs are characterized by an ER stress condition, due to 
protein overload, and by the activation of an adaptive and protective response called the 
unfolded protein response (UPR), finalized to restore normal ER functions {Hetz, 2015 #497} 
{Marciniak, 2006 #485}. ER stress triggers the UPR through three sensors present in the ER 
membrane: inositol-requiring enzyme 1 (IRE1), PKR-like ER kinase (PERK) and activating 
transcription factor 6 (ATF6). These sensors are normally maintained inactive by association 
to the molecular chaperone BiP {Chakrabarti, 2011 #285}. UPR targets include genes 
encoding for chaperones, molecules involved in ER associated degradation (ERAD), 
membrane remodeling and trafficking {Hetz, 2012 #230}. 
The goal of this work was to understand whether the autism-associated R451C NLGN3 
protein elicits ER stress and UPR activation in mammalian cells. We provide here a detailed 
characterization of UPR pathways in a new model system consisting in PC12 Tet-On cells 
with stable and inducible expression of wild type (WT), R451C NLGN3 or G221R NLGN3. 
G221R substitution in NLGN3 has been used as a positive control mutation because it was 
shown to disrupt the folding of the extracellular domain of NLGN3 and to cause a virtually 
complete retention of the protein in the ER, as demonstrated previously {De Jaco, 2010 #69}. 
Although this mutation is not linked to ASDs, the G2300R mutation in the Tg protein, is 
associated with hypothyroidism, and it causes defective protein intracellular transport due to 
the retention of the mutant protein in the ER {Hishinuma, 2000 #93}. The Gly residue is 
conserved between the two proteins among different species (Fig. 1A) and maps in the core 
of the α/β-hydrolase domain of the neuroligins that is structurally similar to the C-terminal 
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portion of the protein thyroglobulin (Tg) (Fig. 1A) {De Jaco, 2012 #478}.  
Our data provide strong evidence that the retention of NLGN3 caused by the R451C and 
G221R variants induce the activation of UPR with different intensities and timing profiles 
reflecting the impact of each of the mutations on NLGN3 misfolding. We show that all three 
ER stress sensors, ATF6, IRE1 and PERK are activated by the mutant R451C NLGN3 
protein, eliciting the corresponding signaling cascades in a time-dependent manner after 
NLGN3 synthesis. Up-regulation of BiP and C/EBP homologous protein (CHOP) was 
detected in both undifferentiated and differentiated PC12 cells, supporting the hypothesis that 
ER stress and UPR, induced by misfolded proteins, might influence neuronal functioning in 
individuals carrying the mutation. 
 
EXPERIMENTAL PROCEDURES 
Plasmids construction  
PTRE tight Tet-On containing the N-terminal FLAG-tagged full length rat NLGN3 cDNA was 
originated by inserting NLGN3 cDNA fragment from pcDNA3.1 {Comoletti, 2004 #125} in the 
Tet-On pTRE tight vector (Clontech). The luciferase constructs used are the following: 
(5x)ATF6-luc (Firefly) encoding for five tandem copies of the ATF6 consensus binding sites 
upstream of the luciferase gene, and the pRL-TK (Renilla) which provides Renilla luciferase 
constitutive expression as reporter for transfection efficiency. Both luciferase constructs were 
originally from Dr. Timothy Weaver, Cincinnati Children’s Hospital Medical Center (Cincinnati, 
OH) {Davies, 2009 #174}.  
Culture of stable PC12 Tet-On cells  
PC12 Tet-On cells were cultured following supplier guidelines (Clontech). Briefly, cells were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% v/v horse 
serum, 5% v/v Tet-approved fetal bovine serum (FBS, BD Biosciences), 10mM v/v HEPES 
Buffer (PAA), Glutamax 1x (GIBCO), 0.2 U/ml bovine insulin. 
PC12 Tet-On cells were differentiated into neurons by plating onto glass coverslips pre-
treated with 0.1mg/ml poly-L-lysine and 0.1mg/ml rat tail collagen I and culturing in DMEM 
supplemented with 1% v/v horse serum, non-essential amino acids, HEPES buffer, 0.2U/ml 
bovine insulin, 200mg/ml Geneticin, 100mg/ml Hygromycin B (Life Technologies) and 
150ng/ml NGF for 5 days. Tunicamycin treatments of PC12 Tet-On parental cells, used as 
positive controls for UPR activation, occurred for 16 hours at 2mg/ml. Thapsigargin was used 
at 500nM for 16 hours. 
Generation and characterization of stable PC12 Tet-On cell lines expressing NLGN3 
PC12 NLGN3 Tet-On clones were generated by co-transfecting pTRE response plasmid 
encoding for NLGN3 and pTK-Hyg resistance vector, using the Lipofectamine procedure (Life 
Technologies). Transfected cells were cultured in a selective medium containing 150µg/ml 
Hygromycin B and 200mg/ml Geneticin (Life Technologies). Isolated clones were screened 
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for NLGN3 expression by western blot analysis after NLGN3 expression was induced with 
doxycycline (DOX). NLGN3 expression was typically induced with 1µg/ml DOX. MG132 
proteasome inhibitor was added in the medium for the last 16 or 24 hours of culture, 
depending on the experimental procedures at the concentrations ranging from 0.1 to 1mM. 
GSK2606414 (Selleck Chemicals) treatment (50nM in water for 60 minutes) was used to 
evaluate PERK-mediated phosphorylation of eIF2α. 
Preparation of PC12 Tet-On Cell extracts 
Lysates of PC12 cells were prepared using lysis buffer (150mM NaCl, 10mM TRIS buffer pH 
8.0, 0.5% Nonidet P-40) supplemented with protease inhibitor cocktail. Detection of eIF2a 
phosphorylation required a lysis buffer with phosphatase inhibitors (10mM tetrasodium 
pyrophosphate, 15.5mM β-glycerophosphate, 100mM NaF). Lysis occurred for 15 minutes on 
ice, the soluble fraction was cleared by centrifugation at 17,000g for 15 minutes at 4˚C and 
the insoluble pellet was removed. 
Nuclear fraction enrichment 
Cytosolic fraction of PC12 cells was isolated by incubation on ice for 10 minutes with low salt 
buffer for protein lyisis (10mM HEPES pH 7.4, 42mM KCl, 5mM MgCl2, 1mM DTT, 0.5% 
Nonidet P-40 and protease cocktail) followed by centrifugation at 17000g for 10 minutes at 
4°C. While the insoluble pellet was further incubated for 30 minutes on ice with a high salt 
buffer (50mM Tris-Cl pH 7.5, 400mM NaCl, 1mM EDTA, 1% Triton, 0.5% Nonidet P-40, 10% 
glycerol, 2mM DTT and protease cocktail) for nuclear fraction enrichment followed by 
centrifugation at 17000g for 10 minutes at 4°C. Supernatant fraction was used to detect 
CHOP in the nuclei. 
SDS-PAGE and western blot  
Standard techniques for protein analysis included protein quantification by Bradford assay, 
protein separation on 10% w/v acrylamide SDS-PAGE (Bio-Rad) in running buffer (25mM 
Tris, 20mM glycine, 3.5mM SDS) and transfer to Immobilon membranes (Millipore) with 
transfer buffer (25mM Tris, 20mM glycine, 10% v/v Methanol). Membranes were blocked with 
5% non-fat milk in T-TBS (20mM Tris-HCl, pH 7.6, 137mM NaCl, 0.2% Tween). Blocking 
solution for detecting eIF2α phosphorylation used 3% bovine serum albumin (BSA) in PBS. 
The following commercial antibodies were used: anti-NLGN pan mouse monoclonal antibody 
(clone 4F9, cat. number 129-011, Synaptic Systems), anti-Phospho-eIF2α (Ser51) rabbit 
antibody and anti-eIF2α total mouse antibody (Cell Signaling), anti-BiP rabbit polyclonal 
antibody, anti-CHOP mouse monoclonal antibody and rabbit polyclonal anti-GAPDH (Abcam), 
goat polyclonal anti-Lamin A/C (N18, Santa Cruz Biotechnology) and mouse monoclonal anti-
KDEL (Enzo Life Sciences Inc.); mouse βIII Tubulin (MMS-435P, Covance). All the primary 
antibodies were used at the 1:1000 dilutions in PBS 3% BSA. Secondary antibodies were 
diluited in 5% non-fat milk in T-TBS: anti-mouse-HRP and anti-rabbit-HRP (Sigma-Aldrich) 
were diluted 1:10,000 and anti-goat-HRP (Sigma-Aldrich) 1:50,000. 
The HRP signal was developed using the LiteAblot PLUS and TURBO extra sensitive 
chemoluminescent substrates (Euroclone) and exposed to autoradiographic films (Santa Cruz 
Biotechnology) or reveled by using the ChemiDoc™ MP System (BioRad). Densitometric was 
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performed on at least 3 independent experiments using the Image J software (NIH). 
Endoglycosidase H Digestions 
Cell extracts from PC12 NLGN3 Tet-On cells induced for 24 hours by DOX, were denatured 
for 10 minutes using a commercial buffer. Endoglycosidase H (Endo H, New England Biolabs) 
digestion employed 1500 enzymatic units in the provided reaction buffer at 37°C for 3 hours. 
Digests were subjected to SDS-PAGE and immunoblotting using the anti-NLGN commercial 
antibody. 
Immunocytochemistry for Confocal Microscopy 
PC12 Tet-On clones expressing either WT or mutant NLGN3 proteins were plated on glass 
coverslips coated with 0.1mg/ml poly-L-lysine and grown in DMEM. Cells were fixed in 4% 
paraformaldehyde in phosphate-buffered saline (PBS), washed, and incubated with blocking 
buffer (PBS, 2% normal goat serum, 0.5% BSA, and 50 mM glycine) {Comoletti, 2004 #125}. 
Primary antibody incubation has been done using either rabbit anti-FLAG rabbit monoclonal 
antibody (F7425) or an anti-FLAG M2 mouse monoclonal antibody (F3165) in combination 
with: the anti-calnexin rabbit polyclonal antibody (ENZO Life Sciences) diluted 1:200 or an 
anti-CHOP mouse monoclonal antibody (Abcam) diluted 1:200, in 5X diluted blocking buffer. 
Goat secondary anti-rabbit IgG (Rhodamine) and anti-mouse IgG (FITC) antibodies were 
diluted 1:500 in the same buffer (Abcam). Nuclei were stained with 4′,6′-diamino-2-
phenylindole (DAPI). 
Four or five images for each sample were captured at room temperature using a Nikon (Nikon 
Inc.) inverted confocal microscope with ×40 and ×63 objective lenses and processed using 
ImageJ and Adobe Photoshop (Adobe). Sharp merged images were used to confirm NLGN3 
and calnexin co-localization. 
Real-time reverse transcription-PCR 
Total RNA was extracted from PC12 NLGN3 Tet-On cells by using Trizol reagent following 
manufacture’s procedures (Life Technologies). First-strand cDNA was synthesized using the 
Superscript II (Life Technologies) starting from 4 µg of RNA following the manufacturer’s 
recommended protocols. CDNA was amplified by using SYBR Green (Life Technologies) and 
the Applied Biosystems suggested protocol consisting of 40 cycles of amplification with each 
cycle including: 15 seconds at 95°C followed by 60 seconds at 60°C. Real time RT-PCR 
reactions were carried out in the thermocycler iCycler PCR Detection System (Bio-Rad) and 
individual melting curves were produced to assess specificity of each primers set. All assays 
were run in triplicate and relative quantification was calculated using the comparative Ct 
method {Livak, 2001 #477}. 
Used primer sets are: BiP forward 5’-TACTCGAATTCCAAAGATTCAG, reverse 5’-
TCAAGCAGAACCAGGTC; XBP1s forward 5’-ATGGATGCCCTGGTTGCTGAA, reverse 5’-
CCTGCACCTGCTGCGGACT; 18s forward 5’-ACGGACCAGAGCGAAAGCAT-3’, reverse 5’-
TGTCAATCCTGTCCGTGTCC-3’; GAPDH forward 5’-GTGCCAGCCTCGTCTCATAG-3’, 
reverse 5’-TGATGGCAACAATGTCCACT-3’. 
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Luciferase Assay 
PC12 NLGN3 Tet-On clones were seeded on 0.1mg/ml poly-L-lysine pre-coated 6-wells 
plates. After 24h from plating, NLGN3 expression was induced for several times (0, 12, 16, 
24, 48, 72 hours) and transfection with Lipofectamine (Invitrogen) occurred for the last 24h 
using 2mg of total DNA: p(5x)-ATF6-luc (Firefly) and PRL-TK (Renilla) in a 50:1 ratio. Lysis 
buffer provided by the Dual-Luciferase Reporter Assay (Promega) was used for harvesting 
the cells and the substrates included in the kit were used for determining Firefly and Renilla 
luciferase activities. GloMax multi+ detection system (Promega), provided of injectors for 
substrate disposal, was used for detecting the luminescence signals. The luciferase activity 
was calculated as a ratio of the Firefly to Renilla value relative to the -DOX condition. All 
measurements were done in triplicate. 
All other reagents, buffers, culture media and serum for cell cultures were purchased from 
Sigma-Aldrich. 
Statistical Analysis 
All the experiments were performed at least three times on independent samples.  
For all the experiments, one-way ANOVA followed by Bonferroni post-hoc test were used for 
statistical analysis by using Prism5 (Graph-Pad 5 Software Inc.): *P<0.05, **P<0.01, 
***P<0.001, ns refers to non-significant. 
RESULTS 
Generation of PC12 Tet-On clones with NLGN3 inducible expression. 
Time dependent activation of the UPR was studied in the pheochromocytoma PC12 cell line, 
modified with the Tet-On gene regulatory system (Clontech). This line was chosen because it 
can be differentiated into a neuronal-like phenotype by a treatment with nerve growth factor 
(NGF) {Greene, 1976 #164}. PC12 Tet-On cell lines were generated by transfecting the 
doxycycline (DOX)-inducible pTRE-tight vector containing the cDNAs encoding for WT, 
R451C or G221R NLGN3, all FLAG-tagged.  
Stably transfected PC12 Tet-On clones expressing NLGN3 were screened for DOX-induced 
NLGN3 synthesis. Clones grown in the absence of DOX were used to assess the stringency 
of the Tet-On expression system. We have used the G221R mutation because the position of 
the residues in the protein structure and the nature of the amino acid change severely affects 
folding of the extracellular domain of NLGN3. In fact Gly221 is found in the core of the α/β-
hydrolase domain (Fig. 1A) and the substitution with a bulky Arg side chain likely causes 
complete misfolding as indicated by more extensive trypsin proteolysis {De Jaco, 2010 #69}.  
Representative clones were chosen based on NLGN3 protein levels (Fig. S1A) and real time 
RT-PCR analysis was used to select WT and mutant clones expressing comparable levels of 
NLGN3 messenger (Fig. S1B). Three selected clones WT, R451C-2 and G221R-1 were 
chosen and, for simplicity, for the rest of the study they will be named R451C and G221R. 
Western blot analysis on cell lysates was used for detecting NLGN3 expression in a time-
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dependent manner (Fig. 1B). The clone expressing WT NLGN3 showed the presence of a 
completely processed NLGN3 protein visible as a ~110 kDa band. In contrast, the R451C 
NLGN3 mutant protein showed the appearance of two main bands (mature and immature 
glycosylated forms) with apparent molecular weight ranging from ~100 kDa to ~110 kDa 
representing the folding intermediates arising from the slower processing caused by the 
mutation {De Jaco, 2010 #69}. G221R NLGN3 mutant appeared as single band of ~100kDa 
representing the ER, immature form (Fig. 1B). 
To confirm that the mutant proteins were ER retained, we have used immunofluorescence co-
localization analysis with the ER-marker calnexin. WT NLGN3 localized to the cell membrane 
while R451C NLGN3 showed partial ER retention and G221R complete co-localization with 
calnexin, confirming our previous observations (figure 2A) {De Jaco, 2006 #75}. Sensitivity to 
endoglycosidase H (Endo H) was used to detect the presence of immature high-mannose N-
glycans typical of ER-retained proteins (Fig. 2B). As expected, NLGN3 WT protein was 
resistant to the enzymatic digestion, as indicated by the absence of a band-shift upon Endo H 
digestion. In contrast, only the faster migrating band of R451C NLGN3 showed a band shift 
after digestion, indicating partial ER retention. G221R NLGN3 mutant protein showed a 
complete digestion to a lower de-glycosylated band (Fig. 2B) confirming the virtually complete 
retention of mutant protein in the ER {De Jaco, 2010 #69}.  
To ascertain whether the involvement of ERAD might explain the lower levels of protein 
expression for the R451C and G221R mutants in comparison to WT, we have treated the 
PC12 clones with different concentrations of the proteasome-inhibitor MG132 (Fig. 2C). We 
observed a significant increase in the levels of the mutant proteins after the treatment with 
MG132 (0.5 µM and 1µM), while NLGN3 WT levels remained unaltered. Consistent with our 
previous findings {De Jaco, 2010 #69}, this is indicating that the mutant proteins undergo 
through protein degradation via ERAD (Fig. 2C). 
 
Mutant R451C and G221R NLGN3 activate the transcriptional arm of UPR.  
We next studied the activation of each UPR branch driven by ATF6, IRE1 and PERK in our 
cell model, by performing time course experiments. We first analyzed the activation of UPR 
by using a reporter for the ER stress elements (ERSE) found in the promoter of selected 
target genes containing binding sites for ATF6 (pATF6(5x)-Luc). The UPR signaling started 
by the activation of ATF6 is characterized by the ATF6 translocation to the Golgi apparatus 
followed by cleavage of a shorter cytoplasmatic fragment that is translocated into the nucleus 
and acts as a transcriptional factor. We have co-transfected the PC12 clones with the 
pATF6(5x)-Luc reporter and the transfection control pKT-Renilla at different times after DOX 
induction (0, 12, 16, 24, 48 and 72 hours). Both mutant proteins induced the highest 
luciferase values between 12 and 24 hours after induction, significantly above the values 
obtained with the WT NLGN3 cells (Fig. 3A). For the mutant proteins, the activation of the 
reporter remained stable during prolonged NLGN3 synthesis and was significantly different 
from the WT. Highest levels of ATF6 activation were achieved by the G221R mutant from 24 
to 72 hours of treatment, reflecting the highest impact of the mutation on NLGN3 folding. 
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Because the R451C and G221R mutations increase NLGN3 degradation through ERAD (Fig. 
2C), we also analyzed the activation of the UPR-reporter after blocking the proteasome with 
MG132. We observed a significant increase in ATF6 in cells expressing R451C and G221R 
NLGN3 when treated with MG132 compared to untreated conditions (Fig. 3B) except for the 
WT NLGN3. These results indicate that R451C and G221R proteins behave as bona fide 
misfolded proteins and that their retention in the ER activates the UPR signaling responsible 
for the transcriptional induction of UPR target genes containing ERSE.  
 
As the ATF6 and XBP1 DNA-binding sites are similar it is possible that the ATF6(5x)-Luc 
reporter containing the ERSE may also partially detect the activation of the UPR branch 
depending on IRE1 {Samali, 2010 #495}. However, because of the lack of specificity of the 
antibodies that recognize the rat protein, we were unable to detect the up-regulated ATF6 
protein levels (data not shown).  
Next we have investigated the specific activation of IRE1 that mediates the unconventional 
splicing of XBP1 mRNA, giving rise to the spliced XBP1 form (XBP1s), which is directly 
involved in the transcriptional activation of UPR target genes containing UPR elements 
(UPRE), such as ERAD components {Urano, 2000 #289}. We quantified XBP1s mRNA 
amount relative to the -DOX condition to evaluate IRE1 activation in our PC12 Tet-On cells 
after inducing NLGN3 synthesis for specific times (0, 16, 24, and 48 hours) (Fig. 3C). Real 
time RT-PCR revealed time-dependent changes in the levels of XBP1s for the R451C and 
G221R NLGN3 expressing cells, relative to the condition where NLGN3 synthesis was not 
induced (-DOX), whereas WT NLGN3 synthesis did not cause statistically significant changes 
in XBP1s levels at any of the time points (Fig. 3C). The trends of XBP1 splicing appeared 
different between the two mutants: the R451C mutation caused an early and dramatic 
increase at 16 hours from synthesis, significantly higher than the WT NLGN3 value, followed 
by its attenuation up to 48 hours. On the other hand, the G221R mutation induced a slower 
but sustained increase in XBP1s levels over time, becoming significantly different from WT 
NLGN3 levels at ~24 and 48 hours. According to the time course data relative to the 
expression of NLGN3 (Fig. 1B), protein levels at 16 hours are rather low in comparison to 
longer times of induction. To explain the peak in the splicing of XBP1 observed for the R451C 
mutant at 16 hours, we have tested whether ERAD was activated at early times. As shown by 
the western blot of the lysates expressing WT and NLGN3 mutant proteins, at 16 hours (Fig. 
3D) in the presence/absence of MG132, the mutant proteins undergo degradation through the 
proteasome as shown by the striking increase observed after the treatment with MG132. This 
is indicating that the mutant protein triggers ER stress signaling and is simultaneously 
degraded by ERAD as early as 16 hours after induction of NLGN3 synthesis. 
 
Mutant R451C and G221R NLGN3 activate PERK-mediated eIF2α phosphorylation  
The phosphorylation of eukaryotic translation initiation factor 2 (eIF2α) integrates multiple 
stress cellular pathways {Harding, 2003 #500}. Regulated phosphorylation of eIF2α by the ER 
stress-activated protein kinase PERK modulates protein synthesis and couples the production 
of ER client proteins with the organelle's capacity to fold and process them {Harding, 2000 
#498}. The activation of the PERK branch is commonly studied using a specific antibody for 
the phosphorylated form of eIF2α. Since eIF2α phosphorylation has been shown to occur 
soon after ER-stress inducing treatments in PC12 cells {Neuber, 2014 #492}, we studied 
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PERK activation upon NLGN3 synthesis after 0, 4, 8, 12, 16, 24 and 48 hours. 
Phosphorylation of eIF2α increased over time with a similar trend for the R451C and G221R 
mutant variants, but not for the WT protein (Fig. 4A, upper panel). The increase was 
detectable starting after 4 hours and reached the highest peak at 12 hours, when the 
differences were significant for both NLGN3 mutants in comparison to WT protein (Fig.4A, 
S2A). Although PERK is required for the phosphorylation of eIF2α specifically by ER stress 
{Harding, 2000 #499}, mammalian cells have other eIF2α kinases (GCN2, PKR and HRI) 
where each of them is activated by different signals {Donnelly, 2013 #462}. To study whether 
the peak of eIF2α phosphorylation comes from the activation of PERK, we made use of the 
highly selective PERK inhibitor, GSK2606414 {Axten, 2012 #501}. We conducted a dose-
response study on the attenuation of P-eIF2α in PC12 cells treated with  tunicamycin and 
thapsigargin, using different concentrations of GSK2606414 (10, 50 and 100 nM, Fig. S2B). 
We then analysed the effect of the drug in reducing the phosphorylation of eIF2a in the PC12 
clones. NLGN3 synthesis was induced by DOX for 12 hours, when the highest peak of 
phosphorylation was observed (Fig. 4A). The inhibitor (50nM) was added for the last hour of 
culturing the cells. The signal relative to the P-eIF2a-Ser51 was analysed by western blot as a 
ratio to the total eIF2a signal. Densitometry show that GSK2606414A reduces significantly the 
phosphorylation of eIF2a in PC12 cells expressing the R451C and G221R mutant proteins but 
not for the WT condition (Fig. 4B). This indicates that the retention of the mutant proteins in 
the ER leads to the activation of the PERK branch along with the ATF6 and IRE1 pathways. 
 
Expression of mutant R451C and G221R NLGN3 causes up-regulation of UPR targets. 
After assessing that all the UPR stress sensors were activated by the NLGN3 mutations, we 
analyzed the steady-state levels of UPR target genes such as CHOP and BiP.  
Under ER stress conditions, the transcription factor CHOP is synthesized, thus leading to 
UPR activation. CHOP also has a role in regulating ER client protein load and the oxidizing 
conditions in the organelle {Marciniak, 2004 #157}. Upon DOX induction, western blot 
revealed that CHOP was present in the nuclear extracts from R451C and G221R NLGN3 
expressing cells, but not in the NLGN3 WT sample and in the cells not treated with DOX (Fig. 
5A, upper panel), indicating that CHOP induction was dependent on synthesis of the NLGN3 
mutants (Fig. 5A, lower panel). Further evidence of CHOP induction by the NLGN3 mutants 
expression was obtained with the immunohistochemical analysis using the same anti-CHOP 
antibody (Fig. 5B). Whereas the majority of R451C and G221R NLGN3 over-expressing (or 
tunicamicin treated) cells showed specific staining for CHOP in their nuclei, specific staining 
was not observed in cells expressing WT NLGN3.  
A classical target induced under ER stress conditions is BiP that is regulated by the ERSE 
found in its promoter region {Takayanagi, 2013 #476}. Quantification of the messenger levels 
for BiP was carried in a time course experiment ranging from 0 to 72 hours after DOX-induced 
NLGN3 protein synthesis, relative to the -DOX condition. Although the synthesis of WT 
NLGN3 did not alter BiP expression over time (Fig. 6A, black circles), synthesis of R451C 
NLGN3 caused a robust increase of BiP expression at 16 hours (Fig. 6A open squares), 
followed by a progressive attenuation at 24 and 48 hours, but remaining significantly different 
from the values of the WT NLGN3 protein. However, at 72 hours the values for the R451C 
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showed a decrease almost reaching WT values. For the G221R NLGN3 mutation, a slower 
but progressive increase was detected (Fig. 6A, black triangles), throughout the entire testing 
period. 
To further investigate the effects of the NLGN3 mutations on the up-regulation of BiP, we 
measured the levels of the protein following DOX induction of NLGN3 synthesis. Whereas the 
expression of BiP is unchanged over time following NLGN3 WT-induced expression, both 
mutants cause a progressive up-regulation of BiP (Fig. 6B) when compared with the –DOX 
condition. Interestingly, the synthesis of the G221R mutant causes BiP increased protein 
levels over-time following the same general trend observed for the messenger (Fig. 6A). 
Whereas for the R451C mutant protein, in contrast to the messenger, BiP protein levels 
remain increased even at later time points (Fig. 6B). Quantification of BiP levels normalized to 
the GAPDH loading control done at the 24 hours time point (Fig. 6C) shows a significant 
increase in BiP levels only for the mutants, but not for the WT conditions. 
Next, we have induced the differentiation of our PC12 cells to a neuronal-like phenotype by 
72 hours treatment with NGF (Fig. 7) and we have quantified the levels of the Grp94 and BiP 
ER chaperones, after NLGN3 WT and mutants induction. We have used an antibody that 
recognizes the KDEL sequence, common to both chaperons, whereas βIII-Tubulin was used 
to confirm the differentiation state (Fig. 7, lower panel) of the PC12 cells. As expected, 
densitometric analysis showed a significant increase of GRP94 and BiP expression for both 
R451C and G221R variants, but not for WT (Fig. 7). These results are in agreement with our 
previous data using stably transfected HEK-293 cells, showing that BiP and Grp94 are the 
chaperone proteins that preferentially take part in the folding of R451C and G221R NLGN3 
{De Jaco, 2010 #69}.  
 
DISCUSSION 
A growing number of neurological genetic diseases are characterized by the accumulation of 
misfolded protein within the ER {Roussel, 2013 #466}. This can lead to the perturbation of ER 
homeostasis and to the activation of UPR, an adaptive cellular response that aims to restore 
proper functioning of the organelle through the modulation of gene expression {Patil, 2001 
#465}. Several mutations in synaptic protein genes have been identified in ASDs patients, 
suggesting that abnormal synaptic functions are risk factors for neurodevelopmental disorders 
{Kleijer, 2014 #491}. The current knowledge regarding the potential link between ASDs and 
ER stress is minimal and mainly regards autism-associated mutations in CNTNAP2 {Falivelli, 
2012 #175} and in the synaptic adhesion protein CADM1 {Fujita, 2010 #486}. 
Here we focused on the R451C substitution in NLGN3 that represent the most characterized 
autism-linked mutation among the neuroligins. Our previous work has shown that the Arg to 
Cys substitution locally affects the folding of the extracellular protein domain causing partial 
retention of the mutant protein in the ER {De Jaco, 2010 #69}. The misfolding results in a 
diminished trafficking of the protein to the cell surface, which explains, in part, the reduced 
effectiveness of NLGN3 to induce clustering of proteins at the synapse in cultured neurons 
{Chubykin, 2005 #482}. We have compared the R451C mutation to the G221R, which causes 
global misfolding and complete ER retention of NLGN3 {De Jaco, 2010 #71;De Jaco, 2010 
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#69;De Jaco, 2012 #478}. Moreover the G221R homologous mutation in the C-terminal 
region of TG (G2300R), a sub-domain that structurally resembles the extracellular domain of 
the NLGNs, leads to the activation of UPR in human and rat tissues {Baryshev, 2004 #167}. 
The newly generated PC12 Tet-On inducible model system allowed us to study the UPR 
signaling in time course experiments at early and late times after induction of NLGN3 
synthesis. Expression of either R451C or G221R NLGN3 mutant proteins caused higher 
activation, in comparison to WT, of the transcriptional factors of UPR, including the ER stress 
sensor ATF6 (Fig. 3A, 3B) and the spliced form of the transcription factor XBP1 (Fig. 3C). The 
trend of the UPR response evoked by the mutant proteins over time correlates with the 
severity of the mutation and its impact on NLGN3 folding suggesting a direct link between 
mutant genotype and the phenotype of the cellular response. In fact, for ATF6 and XBP1 the 
different trend reflects the severe and milder effects of the G221R and R451C mutations, 
respectively, in the folding of NLGN3 and their position in the structure {Fabrichny, 2007 
#122}, with the R451C being more superficial and the G221R buried in the core of the 
extracellular domain (Fig. 1A). The impact of the mutations on the protein folding is reflected 
in the different glycosylation processing of the two NLGN3 variants: whereas the G221R 
undergoes a progressive accumulation in the ER over time (Fig. 1B and S1C), a small fraction 
of the R451C protein completes its maturation processing and reaches the cell surface (Fig. 
1B, 2B and Fig. 2A). The existence of the two fractions may explain the observation of a 
sudden increase of UPR at 16 hours that decreases with time (48-72 hours), when protein 
degradation is paired with the exit of a fraction of the protein from the ER (Fig. 2C). In fact, 
here we show that degradation of the mutant proteins begins early (Fig. 3D). On the other 
hand, as the G221R mutant protein remains completely in the ER (Fig.1B), the misfolded 
protein accumulate slowly showing signs of ER overload from early time points. 
Increased eIF2α phosphorylation, mediated by PERK, was induced by mutant NLGN3 
proteins but not by the WT protein (Fig. 4A), supporting previous evidence on the eIF2α 
phosphorylation occurs immediately after an insult to transiently attenuate protein synthesis 
{Donnelly, 2013 #471} {Wek, 2007 #489}. Recently, a number of small molecules have been 
identified for inhibiting key mediators of the ER stress signaling {Maly, 2014 #502}. These 
compounds can be used as modulators of UPR and for dissecting the contribution of the UPR 
signaling proteins to pathogenesis in a range of human ER stress–related diseases {Hetz, 
2013 #503}. We have used GSK2606414 for selectively inhibiting PERK and to test the 
hypothesis that the phosphorylation of eIF2α is dependent upon the activation of PERK and 
not by other kinases of the integrate stress response {Harding, 2003 #500}. Consistently, 
GSK2606414 significant decrease of eIF2α phosphorylation is caused by R451C and G221R 
expression, indicating a direct involvement of PERK in the inactivation of eIF2α (Fig. 4C).  
 
The synthesis of CHOP, not generally expressed under physiological conditions {Han, 2013 
#475}, was found to be activated only when R415C and G221R synthesis, but not when WT 
NLGN3 was induced (Fig. 5A, 5B). The transient increase observed for the BiP messenger 
levels for the R451C NLGN3 mutant resulted in higher BiP protein levels in both 
undifferentiated (Fig. 6) and in neuron-like differentiated cells (Fig. 7), suggesting additional 
regulatory mechanisms at the translation level 
Downstream effects of UPR have been found in PC12 NLGN3 Tet-On cells differentiated to a 
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neuronal phenotype. This supports the relevance of the UPR elicited by the ER retention of 
misfolded R451C NLGN3, which might in turn play a role in neuronal behaviour. In fact, 
although the UPR is classically linked to protein folding stress under pathological conditions, it 
is becoming clear that UPR signaling also regulates various processes, including synaptic 
functions {Nosyreva, 2010 #479}. At the molecular levels, subtype-selective modulation of cell 
surface receptors by CHOP has been reported {Sauter, 2005 #467} and the phosphorylation 
of eIF2α has been associated to synaptic plasticity, learning and memory {Costa-Mattioli, 
2007 #494;Di Prisco, 2014 #504}. Moreover, in vivo administration of GSK2606414 has been 
shown to affect memory consolidation, supporting the role of UPR and its mediators in 
mediating synaptic functions {Ounallah-Saad, 2014 #505}.  
In conclusion, in our inducible PC12 model system, the partial misfolding caused by the 
R451C autism-linked mutation in NLGN3 activated the UPR, resulting in reduced protein 
synthesis through phosphorylation of eIF2α and by increasing the ER protein folding and 
degradative capacities through transcriptional activation by XBP1 and ATF6. The activation 
was transient, time-dependent and reflected by the severity of the structural alterations 
caused by the mutations. Our data in PC12 NLGN3 Tet-On cells represent the first detailed 
evidence on UPR signaling cascades promoted by autism-linked mutations in the synaptic 
proteins NLGNs characterized by the retention in the ER.  
The mouse model expressing the R451C NLGN3 protein as endogenous protein exhibits 
social behavioral traits typical of autism along with neurotransmission alterations, not 
observed in the NLGN3 KO mice {Tabuchi, 2007 #143;Etherton, 2011 #287;Pizzarelli, 2011 
#474}. The gain-of-function pathogenic mechanism caused by the mutation could be 
explained by the residual fraction of R451C NLGN3 mutant protein that, reaching the surface, 
is interacting with ligands other than NLGN3. However this hypothesis does not exclude that 
ER stress, induced by the intracellular fraction of mutant NLGN3, might be an additional factor 
taking part to the gain-of-function phenotype. 
To gain insights into the potential role of UPR in neurodevelopmental disorders it will be 
critical to test whether these cellular responses are maintained in vivo, and whether the gain 
of function origins at the cellular level. 
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FIGURE LEGENDS 
 
Figure 1. Structure of NLGN3 and time course of expression in inducible PC12 Tet-On 
clones.  
A. Upper panel: overlay of the three dimensional structure of the a/b-hydrolase domain of 
NLGN (blue) and the c-terminal region of Tg (gray). The location of the R451C (orange) and 
G221R (magenta) mutations in the structure are shown. Lower panel: magnification of the 
homologous region between NLGN and TG where the G221/G2300 are located. The 
sequence alignment of the same region shows that the Gly residue is highly conserved in 
NLGN3 and TG in different species. B. NLGN3 expression in lysates from PC12 Tet-On 
clones induced for several times with DOX (0-72 hours). WT NLGN3 protein appeared as a 
completely processed band (upper panel). The R451C NLGN3 mutant showed two bands 
corresponding to the unprocessed and processed forms (middle panel). The G221R mutant 
protein appeared a single lower mass molecular band, in comparison to WT, typical of 
incompletely glycosylated proteins retained in the ER (lower panel). WT lysates at 24h from 
DOX was used as a control in each panel. 
 
Figure 2. Localization and degradation of NLGN3 in inducible PC12 Tet-On clones 
A. NLGN3 localization in PC12 NLGN3 Tet-On cells differentiated for 5 days with NGF. WT 
NLGN3 detection (FLAG, red) did not show any co-localization with calnexin (green). In 
contrast the R451C mutant protein is partially accumulated in the ER, as shown by the co-
localization with calnexin (yellow). DAPI (blue) was used to stain the nuclei. B. Endo-H 
treatment of cell extracts showed partial and complete digestion of different proteins. C. 
NLGN3 protein levels detected after 48 hours by DOX treatment and 24 hours by MG132 
(0.1, 0.5 and 1µM). WT NLGN3 (upper panel); R451C (middle panel) and G221R NLGN3 
(lower panel). GAPDH was used as loading control. NLGN3/GAPDH densitometric analysis 
was normalized to WT NLGN3 value in the absence of MG132. Statistical analysis compared 
treated and untreated conditions within each clone (n=4). 
 
Figure 3. Activation of the UPR transcriptional factors 
A. PC12 NLGN3 Tet-On clones were transfected with the luciferase reporter vectors after 
NLGN3 synthesis was induced by DOX (from 0 to 72 hours). For each clone, Firefly/Renilla 
ratio, at each time points, is normalized to the –DOX condition. Data represent the mean 
value ± SEM of six independent experiments. Mutants versus WT values, for all time points: 
***P<0.001, except for R451C at 48 hours *P<0.05 and 72 hours **P<0.01. R451C versus 
G221R at 24h and 48h: **P<0.01. B. NLGN3 expression was induced for 48 hours by DOX 
and 0.5mM MG132 was added for the last 24 hours. Data represent the mean value ± SEM of 
five independent experiments (***P<0.001 and **P<0.01). C. NLGN3 synthesis was induced, 
from 0 to 48 hours, and the splicing of XBP1 was quantified by real time RT-PCR using 
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primers amplifying only the XBP1 spliced form. Changes in XBP1s were calculated relative to 
the 18S HKG and normalized to –DOX condition. For each time point, statistical relevance of 
4 independent experiments was calculated comparing NLGN3 mutants to WT. A peak value 
of spliced XBP1 was observed at 16 hours from DOX induction in the R451C NLGN3 cells 
(open squares; R451C versus WT, ***P<0.001; R451C versus G221R, **P<0.01) while 
G221R NLGN3 overexpression caused a slower but steady XBP1 splicing increase (triangles, 
*P<0.05 at 24h and **P<0.01 at 48h). XBP1 splicing in WT NLGN3 clone was unchanged with 
time (circles). D. NLGN3 protein levels were quantified after DOX-induced NLGN3 synthesis 
occurred for 16 hours in the presence or absence of MG132 (0.5 µM). Western blot is 
representative of at least 4 independent experiments. 
 
Figure 4. PERK branch activation 
A. Upper panel: Time course densitometric analysis of western blot for P-eIF2a from 0 to 48 
hours from DOX treatment and normalized to total eIF2a levels.  Significant differences were 
observed for R451C and G221R NLGN3 mutant clones at 12 hours from DOX treatment 
(quadrangles **P<0.01 and triangles ***P<0.001 respectively) in comparison to WT (circles). 
Mean ±SEM values were from 4 independent experiments. Lower panel: representative 
western blot from PC12 NLGN3 Tet-On clones at 12 hours after DOX administration. Tun, 
Tunicamycin. B. Densitometry of P-eIF2a normalized to total eIF2a from 4 independent 
experiments on PC12 clones at 12 hours from DOX induction, without or with 50nM 
GSK2606414 treatment. Comparison between GSK untreated versus treated condition 
(*P<0.05), R451C (**P<0.01) and G221R (***P<0.001). Mean ±SEM values were from 4 
independent experiments. 
 
Figure 5. Expression levels of the UPR target CHOP 
A. Nuclear and cytoplasmic fractions were extracted from PC12 NLGN3 Tet-On clones at 24h 
from DOX administration. Upper panel: detection of CHOP protein was revealed in the 
nuclear fraction of R451C and G221R mutant over-expressing clones while it was absent in 
the WT NLGN3 condition. Parental PC12 cells (mock) and –DOX condition were used as 
negative controls and Tunicamycin treatment as positive control. Nuclear fraction was 
normalized to Lamin A/C protein. Western blot is representative of four independent 
experiments. Lower panel: NLGN3 induced-synthesis was shown by western blot analysis of 
the cytoplasmic protein fraction and GAPDH protein was the loading control. B. Differentiated 
PC12 NLGN3 Tet-On clones after DOX-induction stained with anti-CHOP antibody (green) 
and anti-FLAG for NLGN3 detection (red). R451C and G221R NLGN3 over-expressing cells 
showed positive nuclei for CHOP staining that were absent in the WT NLGN3 clone (upper 
panel). Tunicamycin treated (Tun) parental PC12 cells were used as positive UPR control 
(lower panel).  
 
Figure 6. Up-regulation of the UPR target BiP 
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A. NLGN3 expression was induced from 0 to 72 hours by DOX and BiP messenger levels 
were quantified. Time point values were normalized to –DOX for each clone and statistically 
compared to WT. Values ±SEM are the mean of 4 independent experiments. At 16 hours 
from DOX, a robust increase of BiP mRNA is observed in the NLGN3 R451C (quadrangles 
**P<0.01) respect to WT (circles) and is still significant at 48 hours (*P<0.05). The G221R 
mutation caused a moderate but constant increase over the time becoming gradually 
significant from 24 to 72 hours (triangles *P<0.05 at 24h, **P<0.01 at 48h, ***P<0.001 at 72h). 
BiP mRNA levels showed a flat trend for the WT NLGN3 clone over the time. Comparison 
between R451C and G221R revealed significant differences between the mutants at 72h, 
*P<0.05. B. Representative time course of NLGN3 expression, from 0 to 72 hours by DOX, 
and western blot for the detection of BiP protein levels. Increase in BiP protein levels is 
observed over time only for the PC12 clones expressing the mutant proteins. C. Densitometry 
(n=4) of BiP normalized to GAPDH levels was calculated after inducing NLGN3 synthesis by 
DOX for 24h. A significant increase in BiP levels is observed only for the mutant proteins 
when comparing the +DOX to the –DOX conditions (R451C versus -DOX *P<0.05, G221R 
versus -DOX **P<0.01) but not for the WT. 
 
Figure 7. Levels of Grp94 and BiP in differentiated PC12 NLGN3 Tet-On clones. 
Densitometry of three independent western blot experiments for detecting Grp94 (left) and 
BiP (right) in the lysates from mutant and WT clones at 72 hours from NGF and DOX 
treatment. R451C and G221R NLGN3 showed a significant increase of the two chaperones in 
comparison to the differentiated cells in the absence of DOX. WT NLGN3 cells didn’t show 
any significant change (*P<0.05, **P<0.01, ***P<0.001). B. Representative western blot of 
NGF differentiated PC12 NLGN3 Tet-On cells using the anti-KDEL antibody. Increased 
protein levels for Grp94 and BiP were observed, only for the mutant proteins, when 
comparing the +DOX to the –DOX condition. BIII-tubulin was used as a marker for 
differentiation. Undifferentiated parental PC12 cells treated with Tunicamycin were used as 
positive control and GAPDH as loading control. 
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Supplementary Figures 
 
Supplemental Figure 1 
Selection and characterization of Neuroligin3 expressing clones. 
A. Representative western blot of NLGN3 expressing clones after selection of stable 
transfected PC12 cells. The image shows two clones for each of the mutants that resulted to 
express different protein levels of NLGN3. B. Real time RT-PCR analysis for quantification of 
NLGN3 messenger levels was used to select clones with statistically comparable expression 
levels (n=3). C. Time-course of NLGN3 expression profile of WT, R451C and G221R DOX-
treated selected clones. 
Supplemental Figure 2 
Time dependent phosphorylation of eIF2α  
A. Time course experiment for the detection of P-eIF2αand total eIF2α over time. 
Representative of one out of 4 experiments used for the densitometry in Fig. 4A. Each panel 
includes one clone and different times from DOX treatment: WT protein (upper panel), R451C 
(middle panel) or G221R NLGN3 (lower panel). PC12 parental cells untreated (mock) or 
treated with Tun are respectively the negative and positive controls. Phosphorylation of eIF2a 
is dependent on the expression of the mutant proteins and changes over time. B. Upper 
panel: Tunicamycin and Thapsigargin induced-P-eIF2αin PC12 cells treated with and without 
(-) different concentrations of GSK2606414. Lower panel: densitometry of P-eIF2a normalized 
to eIF2a of western blot in the upper panel. The 50nM concentration has been used for the 
experiments on the clones. 
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